A leading Contract Research and Development Organization (CRDO) – Arcinova has invested in a Uniqsis FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a ...

The current trend in the pharmaceutical industry for the manufacture of small-molecule therapeutic agents is moving toward continuous flow processes. This article is part of a special issue on APIs.

Pharmaceutical manufacturing has traditionally been performed using batch process techniques. Batch processes have been proven over many decades of use, but can have shortcomings when it comes to ...

Reducing the manual labour associated with chemical synthesis by using continuous-flow reactors that not only make compounds, but also purify them, opens up new ...

The FlowSyn Continuous Flow Reactor from Uniqsis now gives chemists the freedom to choose the FlowSyn system with the appropriate flow path material best suited to their particular chemistry. Flow ...

In recent years, continuous flow chemistry has evolved into a powerful platform for molecular assembly that is making an impact on organic synthetic chemistry. Unlike conventional batch method, ...

SAFC offers commercial and pilot-scale continuous-flow capacity. SAFC Commercial, the custom manufacturing services business unit of Sigma-Aldrich, has installed a new commercial-scale continuous flow ...

The antibiotic cefazolin is an essential drug according to the World Health Organization (WHO). It is usually produced via batch manufacturing, but this multistep process is time-consuming, wasteful ...

Argonne ‘s Advanced Synthesis in Continuous Flow Reactor program applies powerful analysis and characterization tools to understand processes at the atomic level to advance manufacturing of fine ...